The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Achalasia Treatment Market Research Report 2024
Synopsis
Achalasia is a rare disorder that makes it difficult for food and liquid to pass from the swallowing tube connecting your mouth and stomach (esophagus) into your stomach. Achalasia occurs when nerves in the esophagus become damaged.
Global Achalasia Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Achalasia Treatment market research.
Key companies engaged in the Achalasia Treatment industry include Bausch Health US LLC, Pfizer, Accordhealthcare, AdvaCare Pharma, Merz Therapeutics, Galderma, Zydus Pharmaceuticals (USA) Inc, Teva pharmaceutical industries ltd and Ohio State Medical Center, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Achalasia Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Achalasia Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Achalasia Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bausch Health US LLC
Pfizer
Accordhealthcare
AdvaCare Pharma
Merz Therapeutics
Galderma
Zydus Pharmaceuticals (USA) Inc
Teva pharmaceutical industries ltd
Ohio State Medical Center
Segment by Type
Calcium Channel Blockers (CCBs)
Nifedipine
Botulinum Toxin Injection
Others
Segment by Application
Hospitals
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Achalasia Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Achalasia is a rare disorder that makes it difficult for food and liquid to pass from the swallowing tube connecting your mouth and stomach (esophagus) into your stomach. Achalasia occurs when nerves in the esophagus become damaged.
Global Achalasia Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Achalasia Treatment market research.
Key companies engaged in the Achalasia Treatment industry include Bausch Health US LLC, Pfizer, Accordhealthcare, AdvaCare Pharma, Merz Therapeutics, Galderma, Zydus Pharmaceuticals (USA) Inc, Teva pharmaceutical industries ltd and Ohio State Medical Center, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Achalasia Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Achalasia Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Achalasia Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bausch Health US LLC
Pfizer
Accordhealthcare
AdvaCare Pharma
Merz Therapeutics
Galderma
Zydus Pharmaceuticals (USA) Inc
Teva pharmaceutical industries ltd
Ohio State Medical Center
Segment by Type
Calcium Channel Blockers (CCBs)
Nifedipine
Botulinum Toxin Injection
Others
Segment by Application
Hospitals
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Achalasia Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Achalasia Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Calcium Channel Blockers (CCBs)
1.2.3 Nifedipine
1.2.4 Botulinum Toxin Injection
1.2.5 Others
1.3 Market by Application
1.3.1 Global Achalasia Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Achalasia Treatment Market Perspective (2018-2029)
2.2 Achalasia Treatment Growth Trends by Region
2.2.1 Global Achalasia Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Achalasia Treatment Historic Market Size by Region (2018-2023)
2.2.3 Achalasia Treatment Forecasted Market Size by Region (2024-2029)
2.3 Achalasia Treatment Market Dynamics
2.3.1 Achalasia Treatment Industry Trends
2.3.2 Achalasia Treatment Market Drivers
2.3.3 Achalasia Treatment Market Challenges
2.3.4 Achalasia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Achalasia Treatment Players by Revenue
3.1.1 Global Top Achalasia Treatment Players by Revenue (2018-2023)
3.1.2 Global Achalasia Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Achalasia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Achalasia Treatment Revenue
3.4 Global Achalasia Treatment Market Concentration Ratio
3.4.1 Global Achalasia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Achalasia Treatment Revenue in 2022
3.5 Achalasia Treatment Key Players Head office and Area Served
3.6 Key Players Achalasia Treatment Product Solution and Service
3.7 Date of Enter into Achalasia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Achalasia Treatment Breakdown Data by Type
4.1 Global Achalasia Treatment Historic Market Size by Type (2018-2023)
4.2 Global Achalasia Treatment Forecasted Market Size by Type (2024-2029)
5 Achalasia Treatment Breakdown Data by Application
5.1 Global Achalasia Treatment Historic Market Size by Application (2018-2023)
5.2 Global Achalasia Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Achalasia Treatment Market Size (2018-2029)
6.2 North America Achalasia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Achalasia Treatment Market Size by Country (2018-2023)
6.4 North America Achalasia Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Achalasia Treatment Market Size (2018-2029)
7.2 Europe Achalasia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Achalasia Treatment Market Size by Country (2018-2023)
7.4 Europe Achalasia Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Achalasia Treatment Market Size (2018-2029)
8.2 Asia-Pacific Achalasia Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Achalasia Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Achalasia Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Achalasia Treatment Market Size (2018-2029)
9.2 Latin America Achalasia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Achalasia Treatment Market Size by Country (2018-2023)
9.4 Latin America Achalasia Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Achalasia Treatment Market Size (2018-2029)
10.2 Middle East & Africa Achalasia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Achalasia Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Achalasia Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health US LLC
11.1.1 Bausch Health US LLC Company Detail
11.1.2 Bausch Health US LLC Business Overview
11.1.3 Bausch Health US LLC Achalasia Treatment Introduction
11.1.4 Bausch Health US LLC Revenue in Achalasia Treatment Business (2018-2023)
11.1.5 Bausch Health US LLC Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Achalasia Treatment Introduction
11.2.4 Pfizer Revenue in Achalasia Treatment Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Accordhealthcare
11.3.1 Accordhealthcare Company Detail
11.3.2 Accordhealthcare Business Overview
11.3.3 Accordhealthcare Achalasia Treatment Introduction
11.3.4 Accordhealthcare Revenue in Achalasia Treatment Business (2018-2023)
11.3.5 Accordhealthcare Recent Development
11.4 AdvaCare Pharma
11.4.1 AdvaCare Pharma Company Detail
11.4.2 AdvaCare Pharma Business Overview
11.4.3 AdvaCare Pharma Achalasia Treatment Introduction
11.4.4 AdvaCare Pharma Revenue in Achalasia Treatment Business (2018-2023)
11.4.5 AdvaCare Pharma Recent Development
11.5 Merz Therapeutics
11.5.1 Merz Therapeutics Company Detail
11.5.2 Merz Therapeutics Business Overview
11.5.3 Merz Therapeutics Achalasia Treatment Introduction
11.5.4 Merz Therapeutics Revenue in Achalasia Treatment Business (2018-2023)
11.5.5 Merz Therapeutics Recent Development
11.6 Galderma
11.6.1 Galderma Company Detail
11.6.2 Galderma Business Overview
11.6.3 Galderma Achalasia Treatment Introduction
11.6.4 Galderma Revenue in Achalasia Treatment Business (2018-2023)
11.6.5 Galderma Recent Development
11.7 Zydus Pharmaceuticals (USA) Inc
11.7.1 Zydus Pharmaceuticals (USA) Inc Company Detail
11.7.2 Zydus Pharmaceuticals (USA) Inc Business Overview
11.7.3 Zydus Pharmaceuticals (USA) Inc Achalasia Treatment Introduction
11.7.4 Zydus Pharmaceuticals (USA) Inc Revenue in Achalasia Treatment Business (2018-2023)
11.7.5 Zydus Pharmaceuticals (USA) Inc Recent Development
11.8 Teva pharmaceutical industries ltd
11.8.1 Teva pharmaceutical industries ltd Company Detail
11.8.2 Teva pharmaceutical industries ltd Business Overview
11.8.3 Teva pharmaceutical industries ltd Achalasia Treatment Introduction
11.8.4 Teva pharmaceutical industries ltd Revenue in Achalasia Treatment Business (2018-2023)
11.8.5 Teva pharmaceutical industries ltd Recent Development
11.9 Ohio State Medical Center
11.9.1 Ohio State Medical Center Company Detail
11.9.2 Ohio State Medical Center Business Overview
11.9.3 Ohio State Medical Center Achalasia Treatment Introduction
11.9.4 Ohio State Medical Center Revenue in Achalasia Treatment Business (2018-2023)
11.9.5 Ohio State Medical Center Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
